# Observational Study on 2-chloroprocaine Hydrochloride 1%

> **NCT02067806** · — · COMPLETED · sponsor: **Sintetica SA** · enrollment: 394 (actual)

## Conditions studied

- Neurological Complication, in Particular TNS or CES

## Interventions

- **DRUG:** 2-chloroprocaine hydrochloride, 1%

## Key facts

- **NCT ID:** NCT02067806
- **Lead sponsor:** Sintetica SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 394 (ACTUAL)
- **Last updated:** 2021-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02067806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02067806, "Observational Study on 2-chloroprocaine Hydrochloride 1%". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02067806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*